| 摘要 |
The invention relates to newly identified peptides of that are capable of inducing tolerance to cow's milk, especially to B-lactoglobulin. The peptides may be administered to mammals, especially to young infants who are at risk of allergy to cow's milk proteins, to induce oral tolerance to cow's milk; they may also be administered to children or adults who are allergic to cow's milk to allow "desensitization" towards the allergenic milk proteins, especially B-lactoglobulin, to occur. The peptides may also be used to induce tolerance to goat's and buffalo's milk proteins, especially B-lactoglobulin. The peptides are capable of modulating the mammalian immune response to allergens. |
